🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

549 results for “Hong” Clear

  1. Byfavo

    Hospital Authority, Hong Kong

    Bronchoscopy

    approved small molecule completed

    1 trial

  2. Chlorhexidine gluconate

    Hospital Authority, Hong Kong

    Liver Tumors

    approved small molecule completed

    1 trial

  3. Cinacalcet

    The University of Hong Kong

    Kidney Failure

    approved small molecule completed

    1 trial

  4. Combination Cinacalcet with Vitamin D analogue

    Hospital Authority, Hong Kong

    Secondary Hyperparathyroidism

    approved small molecule active

    1 trial

  5. Continuos epidural infusion

    Hospital Authority, Hong Kong

    Analgesia, Epidural

    approved other active

    1 trial

  6. Cook balloon uterine stent

    Hospital Authority, Hong Kong

    Intrauterine Adhesion

    approved other completed

    1 trial

  7. Danhong injection

    BRIGHT MINDS BIOSCIENCES INC.

    Unstable Angina Pectoris

    approved small molecule completed

    1 trial

  8. Danhong injection

    BRIGHT MINDS BIOSCIENCES INC.

    Acute Stroke

    approved small molecule completed

    1 trial

  9. Dapagliflozin (5-10 mg daily) - SGLT2 Inhibitor Therapy

    The University of Hong Kong

    Fontan

    approved small molecule active

    1 trial

  10. Dexamethasone

    The University of Hong Kong

    Total Knee Replacement

    approved small molecule active

    1 trial

  11. Dexamethasone and N-acetylcysteine (NAC)

    Hospital Authority, Hong Kong

    Carbon Monoxide Poisoning

    approved small molecule active

    1 trial

  12. Dexmedetomidine

    Hospital Authority, Hong Kong

    Thyroid Diseases

    approved small molecule active

    1 trial

  13. Dexmedetomidine

    The University of Hong Kong

    Anxiety, Separation

    approved small molecule active

    1 trial

  14. Dextrose 5%

    Hospital Authority, Hong Kong

    End-Stage Kidney Disease

    approved small molecule active

    1 trial

  15. Etomidate

    Hospital Authority, Hong Kong

    Choledocholithiasis

    approved small molecule completed

    1 trial

  16. Finerenone

    Hospital Authority, Hong Kong

    Heart Failure and Preserved Ejection Fraction

    approved small molecule active

    1 trial

  17. Finerenone

    Chinese University of Hong Kong

    Patients With Type 2 Diabetes

    approved small molecule active

    1 trial

  18. Forsteo

    Hospital Authority, Hong Kong

    Spine Deformity

    approved small molecule active

    1 trial

  19. Group C : Saline + propofol group

    Hospital Authority, Hong Kong

    Urologic Surgery

    approved small molecule completed

    1 trial

  20. Honghe Fujie lotion

    The First People's Hospital of Lianyungang

    Bacterial Vaginitis

    approved small molecule active

    1 trial

  21. Intraosseous

    Hospital Authority, Hong Kong

    Cardiac Arrest

    approved other completed

    1 trial

  22. Intraosseous Morphine

    Hospital Authority, Hong Kong

    Pain Postoperative

    approved other active

    1 trial

  23. Ivabradine + Usual Care

    The University of Hong Kong

    Atrial Fibrillation (Permanent)

    approved small molecule active

    1 trial

  24. Ixekizumab

    Hospital Authority, Hong Kong

    Plaque Psoriasis

    approved mab active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources